Reimbursed
Patient Access
Axes Health leads biotech and pharmaceutical companies from navigating pricing, reimbursement, and early access pathways to bring innovative therapies to BeNeLux patients in a sustainable way.
Integrated Market Access Solutions
We developed a systematic approach ensuring no critical milestone is overlooked
Countries
Benelux serviced
120+
Submissions
+25 yrs
Experience
100%
Excellence
Our expertise
Navigating Pricing & Reimbursement,Guided Patient Access and Real-World Data

Our Mission
Support in Patient Access
Our Purpose
Bringing innovative medicines of pharmaceutical and biotech companies to patients, sustainably and meaningfully
03
02
01
Our approach
Strategic engagement and executional excellence with deep respect for the patient’s voice.
Guided Patient Access
We build localised value stories, providing
end-to-end support
from early access to reimbursement.
Pricing & Reimbursement
We deliver strategic, landscape-driven access planning that minimises delays and rejections, facilitates early stakeholder dialogue, and embeds patient priorities at the core of your access strategy.
OUR SERVICES
How We Service our cutomers
Therapeutic Domains
We bring extensive experience across a broad range of therapeutic domains
Orphan
Diseases
Neurology
Respiratory
Dermatology
Oncology
Cardiology
Haematology
Nephrology
Integrated Market Access Solutions
A systematic approach ensuring no critical milestone is overlooked, from early-stage development to post-launch optimisation.
Landscape Assessment
An in-depth analysis of the current landscape, unmet needs, and payer perceptions.
Value Proposition
Crafting a compelling value story and gathering necessary clinical and economic evidence.
Strategy Development
Defining the optimal pricing, contracting, and access strategy for each target market.
Execution & Launch
Following up on addressing clinical and budgetary uncertainties to maintain patient access.
Why Choose
Axes Health?
Recognised executional excellence.
Deep respect for the patient's voice
Unmatched expertise in rare diseases.
Respected partner by health authorities.


